{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T20:53:58Z","timestamp":1767473638309,"version":"3.37.3"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2018-04546"],"award-info":[{"award-number":["RGPIN-2018-04546"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship"],"award-info":[{"award-number":["Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD019851"],"award-info":[{"award-number":["DP5OD019851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Breast Cancer Alliance","award":["Young Investigator Award"],"award-info":[{"award-number":["Young Investigator Award"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007278","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T17:22:31Z","timestamp":1566840151000},"page":"e1007278","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-4770","authenticated-orcid":true,"given":"Morgan","family":"Craig","sequence":"first","affiliation":[]},{"given":"Kamran","family":"Kaveh","sequence":"additional","affiliation":[]},{"given":"Alec","family":"Woosley","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-146X","authenticated-orcid":true,"given":"Andrew S.","family":"Brown","sequence":"additional","affiliation":[]},{"given":"David","family":"Goldman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-9310","authenticated-orcid":true,"given":"Elliot","family":"Eton","sequence":"additional","affiliation":[]},{"given":"Ravindra M.","family":"Mehta","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-1277","authenticated-orcid":true,"given":"Andrew","family":"Dhawan","sequence":"additional","affiliation":[]},{"given":"Kazuya","family":"Arai","sequence":"additional","affiliation":[]},{"given":"M. Mamunur","family":"Rahman","sequence":"additional","affiliation":[]},{"given":"Sidi","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Martin A.","family":"Nowak","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9129-1311","authenticated-orcid":true,"given":"Aaron","family":"Goldman","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"issue":"1","key":"pcbi.1007278.ref001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"RL Siegel","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"19","key":"pcbi.1007278.ref002","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"MG Kris","year":"2014","journal-title":"JAMA\u2014Journal of the American Medical Association"},{"issue":"4","key":"pcbi.1007278.ref003","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non\u2013Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"DS Ettinger","year":"2017","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"11","key":"pcbi.1007278.ref004","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc.2017.84","article-title":"Understanding and targeting resistance mechanisms in NSCLC","volume":"17","author":"J Rotow","year":"2017","journal-title":"Nature Reviews Cancer"},{"issue":"10","key":"pcbi.1007278.ref005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"C Holohan","year":"2013","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"pcbi.1007278.ref006","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of Cancer Drug Resistance","volume":"53","author":"MM Gottesman","year":"2002","journal-title":"Annual Review of Medicine"},{"issue":"2","key":"pcbi.1007278.ref007","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"DB Longley","year":"2005","journal-title":"Journal of Pathology"},{"key":"pcbi.1007278.ref008","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/ncomms3467","article-title":"Non-Darwinian dynamics in therapy-induced cancer drug resistance","volume":"4","author":"AO Pisco","year":"2013","journal-title":"Nature Communications"},{"key":"pcbi.1007278.ref009","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1038\/ncomms7139","article-title":"Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition","volume":"6","author":"A Goldman","year":"2015","journal-title":"Nature Communications"},{"key":"pcbi.1007278.ref010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrg3317","article-title":"Evolution of the cancer genome","volume":"13","author":"LR Yates","year":"2012","journal-title":"Nature Reviews Genetics"},{"issue":"1","key":"pcbi.1007278.ref011","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","author":"N McGranahan","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"pcbi.1007278.ref012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"I Dagogo-Jack","year":"2018","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"19","key":"pcbi.1007278.ref013","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","article-title":"Intratumor heterogeneity: Evolution through space and time","volume":"72","author":"C Swanton","year":"2012","journal-title":"Cancer Research"},{"issue":"5","key":"pcbi.1007278.ref014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: A looking glass for cancer?","volume":"12","author":"A Marusyk","year":"2012","journal-title":"Nature Reviews Cancer"},{"issue":"6206","key":"pcbi.1007278.ref015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1256930","article-title":"Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing","volume":"346","author":"J Zhang","year":"2014","journal-title":"Science"},{"issue":"1","key":"pcbi.1007278.ref016","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tpb.2010.05.001","article-title":"Evolutionary dynamics of tumor progression with random fitness values","volume":"78","author":"R Durrett","year":"2010","journal-title":"Theoretical Population Biology"},{"issue":"2","key":"pcbi.1007278.ref017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1534\/genetics.110.125724","article-title":"Intratumor heterogeneity in evolutionary models of tumor progression","volume":"188","author":"R Durrett","year":"2011","journal-title":"Genetics"},{"issue":"43","key":"pcbi.1007278.ref018","doi-asserted-by":"crossref","first-page":"18545","DOI":"10.1073\/pnas.1010978107","article-title":"Accumulation of driver and passenger mutations during tumor progression","volume":"107","author":"I Bozic","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"45","key":"pcbi.1007278.ref019","doi-asserted-by":"crossref","first-page":"15964","DOI":"10.1073\/pnas.1412075111","article-title":"Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers","volume":"111","author":"I Bozic","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"pcbi.1007278.ref020","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.1213968110","article-title":"Impact of deleterious passenger mutations on cancer progression","volume":"110","author":"CD McFarland","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"pcbi.1007278.ref021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1073\/pnas.1421839112","article-title":"Only three driver gene mutations are required for the development of lung and colorectal cancers","volume":"112","author":"C Tomasetti","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"pcbi.1007278.ref022","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1073\/pnas.0712345105","article-title":"Comparative lesion sequencing provides insights into tumor evolution","volume":"105","author":"S Jones","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6161","key":"pcbi.1007278.ref023","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1243148","article-title":"Defining stem cell dynamics in models of intestinal tumor initiation","volume":"342","author":"L Vermeulen","year":"2013","journal-title":"Science"},{"issue":"10","key":"pcbi.1007278.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187000","article-title":"Phenotypic heterogeneity in modeling cancer evolution","volume":"12","author":"A Mahdipour-Shirayeh","year":"2017","journal-title":"PLOS ONE"},{"issue":"10","key":"pcbi.1007278.ref025","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1158\/0008-5472.CAN-15-3232","article-title":"Mathematical modeling reveals that changes to local cell density dynamically modulate baseline variations in cell growth and drug response","volume":"76","author":"JM Greene","year":"2016","journal-title":"Cancer Research"},{"key":"pcbi.1007278.ref026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jtbi.2014.02.025","article-title":"Evolution of acquired resistance to anti-cancer therapy","volume":"355","author":"J Foo","year":"2014","journal-title":"Journal of Theoretical Biology"},{"key":"pcbi.1007278.ref027","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"WD Foulkes","year":"2014","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"pcbi.1007278.ref028","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5030036","article-title":"MicroRNA in lung cancer: Novel biomarkers and potential tools for treatment","volume":"5","author":"K Inamura","year":"2016","journal-title":"Journal of Clinical Medicine"},{"issue":"Supp 3","key":"pcbi.1007278.ref029","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1073\/pnas.1400823111","article-title":"The replicator equation and other game dynamics","volume":"111","author":"Ross Cressman","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"unstructured":"Institute NC. Diversity Set VI; 2017. Available from: nci.gov.","key":"pcbi.1007278.ref030"},{"issue":"10","key":"pcbi.1007278.ref031","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.239681.114","article-title":"Global microRNA depletion suppresses tumor angiogenesis","volume":"28","author":"S Chen","year":"2014","journal-title":"Genes & Development"},{"key":"pcbi.1007278.ref032","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1038\/ncomms7169","article-title":"Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity","volume":"6","author":"B Majumder","year":"2015","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1007278.ref033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"A Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"12","key":"pcbi.1007278.ref034","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2013","journal-title":"Genome Biology"},{"issue":"5","key":"pcbi.1007278.ref035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"C Trapnell","year":"2010","journal-title":"Nature Biotechnology"},{"key":"pcbi.1007278.ref036","doi-asserted-by":"crossref","DOI":"10.1007\/b98868","volume-title":"Mathematical Biology I. An Introduction","author":"JD Murray","year":"2002"},{"key":"pcbi.1007278.ref037","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511542633","volume-title":"Evolutionary Game Theory, Natural Selection, and Darwinian Dynamics","author":"TL Vincent","year":"2005"},{"issue":"4","key":"pcbi.1007278.ref038","article-title":"Evolutionary game theory for physical and biological scientists.II. Population dynamics equations can be associated with interpretations","volume":"4","author":"D Liao","year":"2014","journal-title":"Interface Focus"},{"issue":"5 Pt B","key":"pcbi.1007278.ref039","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jmb.2015.10.019","article-title":"Synthetic ecology of microbes: mathematical models and applications","volume":"428","author":"AR Zomorrodi","year":"2016","journal-title":"Journal of Molecular Biology"},{"issue":"4","key":"pcbi.1007278.ref040","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/AAC.49.4.1483-1494.2005","article-title":"Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations","volume":"39","author":"C Wiuff","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"pcbi.1007278.ref041","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/0008-5472.CAN-14-2103","article-title":"Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation","volume":"75","author":"RH Chisholm","year":"2015","journal-title":"Cancer Research"},{"unstructured":"Mathworks. MATLAB 2018a; 2018.","key":"pcbi.1007278.ref042"},{"issue":"23","key":"pcbi.1007278.ref043","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1101\/gad.1848209","article-title":"Dicer1 functions as a haploinsufficient tumor suppressor","volume":"23","author":"M Kumar","year":"2009","journal-title":"Genes & Development"},{"key":"pcbi.1007278.ref044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1253","article-title":"Dicer is essential for mouse development","volume":"35","author":"E Bernstein","year":"2003","journal-title":"Nature Genetics"},{"issue":"6","key":"pcbi.1007278.ref045","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1261\/rna.032680.112","article-title":"In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs","volume":"18","author":"AM Gurtan","year":"2012","journal-title":"RNA"},{"issue":"4","key":"pcbi.1007278.ref046","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1758834013492001","article-title":"Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?","volume":"5","author":"FS Farhat","year":"2013","journal-title":"Therapeutic Advances in Medical Oncology"},{"issue":"3","key":"pcbi.1007278.ref047","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41559-018-0768-z","article-title":"Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer","volume":"3","author":"A Kaznatcheev","year":"2019","journal-title":"Nature Ecology & Evolution"},{"key":"pcbi.1007278.ref048","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fmed.2018.00085","article-title":"Overview on clinical relevance of intra-tumor heterogeneity","volume":"5","author":"G Stanta","year":"2018","journal-title":"Frontiers in Medicine"},{"issue":"13","key":"pcbi.1007278.ref049","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1158\/1078-0432.CCR-14-1213","article-title":"Intratumoral heterogeneity: from diversity comes resistance","volume":"21","author":"A Pribluda","year":"2015","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"pcbi.1007278.ref050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","article-title":"Tumor heterogeneity: Causes and consequences","volume":"1805","author":"A Marusyk","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Reviews on Cancer"},{"key":"pcbi.1007278.ref051","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd.2017.226","article-title":"Drug development in the era of precision medicine","volume":"17","author":"SA Dugger","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"pcbi.1007278.ref052","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trecan.2018.01.001","article-title":"The genetic\/non-genetic duality of drug resistance in cancer","volume":"4","author":"R Salgia","year":"2018","journal-title":"Trends in Cancer"},{"issue":"7","key":"pcbi.1007278.ref053","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s11538-018-0434-2","article-title":"Optimal therapy scheduling based on a pair of collaterally sensitive drugs","volume":"80","author":"N Yoon","year":"2018","journal-title":"Bulletin of Mathematical Biology"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:25:54Z","timestamp":1589027154000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007278"}},"subtitle":[],"editor":[{"given":"Darragh Gerard","family":"McArt","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007278","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2019,8,26]]}}}